Working At Ossium


Who We Are

At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good.

Kevin Caldwell

CEO, Co-Founder & President


Listen to Kevin Speak About Our Vision

Principles


The values we live by

Impact

We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive positive change.

Truth

Embracing the truth empowers us to learn from both our successes and our mistakes. We follow the data wherever it leads.

Ownership

We hold ourselves and each other to the highest bar. We care deeply about the work we do and know that even the smallest details can make a difference.

Inside Look


Day in the Life

Donor Field Services Managers

These donor tissue recovery experts work with our OPO partners to continuously improve our tissue recovery processes.  They are masters of Ossium’s recovery protocols and practices.

Production Associates

These processing experts make our cell therapy products. They are skilled in tissue processing, cell processing, and cryopreservation.

Clinical Trial Project Managers

These project management maestros ensure that our clinical trials are run with diligent care.  They work with clinical investigators and healthcare institutions to manage our research.



Words from the Team

From the first day I started at Ossium, we had a clear goal to save lives. I come to work every day with that in mind. Getting to work on such a critical cause with the wonderful folks at Ossium makes this an incredible place to be.

Margie Mathewson

VP of Business Operations

Margie Mathewson

VP of Business Operations

Dr. Mathewson’s career has focused primarily on helping start-ups and small businesses build out robust operations, from internal structures and systems to external partnerships. Prior to joining Ossium, Dr. Mathewson was the 7th team member at Point, a FinTech start-up offering non-traditional options for home equity funding, where she led Business Operations. While there, she drove development of an underwriting process for nontraditional, complicated customers that allowed funding of Point’s initial set of homeowners, including the first to successfully exit the investment. She also communicated complex mathematical concepts to homeowners to educate them on the Point investment model and how their equity sale would work.

Dr. Mathewson also worked as a consultant for McKinsey & Company, where, among other projects, she helped develop a rapid growth strategy for a successful health system, overhauled a sales and supply chain planning process to improve communication and ensure every customer got what they ordered on time, and restructured the international sales team for a major global telecom. Dr. Mathewson completed her PhD at the University of California, San Diego, where she was an NSF Fellow and founded a successful mentorship program for first generation college students in engineering.

I love working for a company that consistently sparks passion, cultivates my professional growth, and advances patient care. Each of my teammates plays a vital role and our strength, enthusiasm, and dedication combine in order to improve the business and science as a whole. I am proud and fulfilled to be an Ossie!

Hannah Miller

Manager, Cell Manufacturing

Hannah Miller

Manager, Cell Manufacturing

I really appreciate that Ossium has challenged me in ways that totally throw me out of my comfort zone. It's a wonderful place to learn and grow.

Brian Johnstone

VP of Research

Brian Johnstone

VP of Research

For the past 20 years, Dr. Johnstone has been actively involved in translating adult stem cell therapies into treatments for a host of diseases affecting the major organs of the body. In 2004, he co-authored one of the first studies demonstrating the potential for treating cardiovascular diseases with novel adult stem cells isolated from fat.

Since then, Dr. Johnstone has continued to develop and test new medical uses for adult stem cells as part of his own research as well as in collaboration with international academic centers and pharma / biotech firms.

Outside of the research setting, Dr. Johnstone co-founded NeuroFx, an early-stage biotech firm developing a novel therapy for neurological disorders. Dr. Johnstone led the R&D program at NeuroFx for two years, where he was directly responsible for preclinical and chemistry, manufacturing, and controls development activities. He continues to act as an advisor for NeuroFx. Additionally, Dr. Johnstone has formed two other biotech companies, Chemigen, which is developing a small molecule drug for treating Lou Gehrig’s disease, and EmphyMab Biotech (now Allinaire), which is developing biologics to treat serious lung diseases.

Before becoming an entrepreneur, Dr. Johnstone was an early employee at Sangamo Biosciences for 6 years, where he managed the preclinical development program for their lead gene therapy candidate for cardiovascular diseases, which is currently in Phase II clinical testing. Dr. Johnstone received his Ph.D. from the University of Maryland, College Park, and completed a postdoctoral fellowship at the University of California, Los Angeles.




Open Positions

At Ossium, we’re always looking for talented, mission-driven people.


General Application

We’re always looking for talenting individuals who belive in our core mission. Don’t hesitate to fill out the General Application — we’ll find something for you to do!

Follow Us

Read our blog to see the latest Ossium updates.